CHKA and breast cancer: To explore the therapeutic mechanism of CKI in treating BC, a novel system pharmacology strategy (Figure 1), which integrates differentially expressed gene analysis (DEGs), pharmacokinetics synthesis screening, target identification, synergy contribution degree (SCD), network analysis, and therapeutic response index (TRI) calculation, was developed.